4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062701
Chief Executive Officer sold 9,447 shares at an average $16.91 ($159,775)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brumm Joshua T · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-16 | Sale : show line 1 in the form 10b5-1 | −1,610 | $17.90 | $28,819 | 279,602 | D |
| 2026-09-18 | Sale : show line 2 in the form 10b5-1 | −7,837 | $16.71 | $130,956 | 271,765 | D |
| Open-market sales · 9,447 sh · avg $16.91 · $159,775 | ||||||
Loading xslF345X06/wk-form4_1789761722.xml…